About Us
Mission & Vision
Corporate Overview
Management
Board of Directors
Code of Conduct
Core Platforms
Exosome Technology
Avalon Cell
Avalon Rehab
Healthcare Facilities
Investor Relations
News & Events
Contact
Navigation
Overview
News / Events
Press Releases
In The News
IR Calendar
Email Alerts
Company Info
Profile
Management Team
Contacts
Presentations
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
All SEC Filings
Filing Type:
View All
10-K
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEF 14C
EFFECT
NT 10-K
NT 10-Q
PRE 14C
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
UPLOAD
Year:
View All
2020
2019
2018
2017
2016
2015
Date
Form
Description
PDF
XBRL
Pages
08/14/18
424B4
Prospectus filed pursuant to Rule 424(b)(4)
180
08/09/18
EFFECT
Notice of Effectiveness
1
08/08/18
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
08/08/18
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
08/07/18
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-1.1
EX-4.8
EX-5.1
EX-10.30
EX-10.31
EX-23.1
EX-24.2
234
07/31/18
8-K
Current report filing
Documents
EX-10.1
10
07/31/18
3
Initial statement of beneficial ownership of securities
2
07/27/18
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-1.1
EX-4.7
EX-4.8
EX-5.1
EX-23.1
236
07/20/18
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-21.1
EX-23.1
188
07/10/18
3
Initial statement of beneficial ownership of securities
2
3
4
5
6
7
8
9
10
11
12